fanta.bio Sample: CNhs10863
- Species
- human
- CRE Type
- ELA
- Cluster
- 0
- Cell Type Class
- Cardiovascular
15193 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1032 / 9217 (11.2%) | 263 / 92170 (0.3%) | −324.0 | −324.0 | 39.24 |
| HIF1A SRX11007095 | HK-2 Kidney | 1795 / 9217 (19.5%) | 579 / 92170 (0.6%) | −324.0 | −324.0 | 31.00 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1412 / 9217 (15.3%) | 459 / 92170 (0.5%) | −324.0 | −324.0 | 30.76 |
| TP53 SRX19538279 | Osteoblasts Bone | 472 / 9217 (5.1%) | 167 / 92170 (0.2%) | −324.0 | −324.0 | 28.26 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1349 / 9217 (14.6%) | 490 / 92170 (0.5%) | −324.0 | −324.0 | 27.53 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1849 / 9217 (20.1%) | 736 / 92170 (0.8%) | −324.0 | −324.0 | 25.12 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1789 / 9217 (19.4%) | 719 / 92170 (0.8%) | −324.0 | −324.0 | 24.88 |
| SCML2 SRX644728 | 293 Kidney | 1105 / 9217 (12.0%) | 460 / 92170 (0.5%) | −324.0 | −324.0 | 24.02 |
| FOXP1 SRX736067 | LNCAP Prostate | 1330 / 9217 (14.4%) | 734 / 92170 (0.8%) | −324.0 | −324.0 | 18.12 |
| MYH11 SRX265221 | ME-1 Blood | 646 / 9217 (7.0%) | 383 / 92170 (0.4%) | −324.0 | −324.0 | 16.87 |
| BRD4 SRX9419937 | BT-474 Breast | 2255 / 9217 (24.5%) | 1822 / 92170 (2.0%) | −324.0 | −324.0 | 12.38 |
| MED1 SRX9419944 | BT-474 Breast | 2199 / 9217 (23.9%) | 1784 / 92170 (1.9%) | −324.0 | −324.0 | 12.33 |
| BRD4 SRX9419935 | BT-474 Breast | 2231 / 9217 (24.2%) | 1820 / 92170 (2.0%) | −324.0 | −324.0 | 12.26 |
| MED1 SRX9419946 | BT-474 Breast | 2296 / 9217 (24.9%) | 1879 / 92170 (2.0%) | −324.0 | −324.0 | 12.22 |
| MED1 SRX9419945 | BT-474 Breast | 2216 / 9217 (24.0%) | 1843 / 92170 (2.0%) | −324.0 | −324.0 | 12.02 |
| MED1 SRX9419947 | BT-474 Breast | 2201 / 9217 (23.9%) | 1841 / 92170 (2.0%) | −324.0 | −324.0 | 11.96 |
| BRD4 SRX9419936 | BT-474 Breast | 2269 / 9217 (24.6%) | 1903 / 92170 (2.1%) | −324.0 | −324.0 | 11.92 |
| BRD4 SRX9419938 | BT-474 Breast | 2222 / 9217 (24.1%) | 1899 / 92170 (2.1%) | −324.0 | −324.0 | 11.70 |
| BRD4 SRX736201 | 90-8TL Neural | 3976 / 9217 (43.1%) | 4016 / 92170 (4.4%) | −324.0 | −324.0 | 9.90 |
| EZH2 SRX2146136 | LNCAP Prostate | 4748 / 9217 (51.5%) | 5035 / 92170 (5.5%) | −324.0 | −324.0 | 9.43 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1266 / 9217 (13.7%) | 1562 / 92170 (1.7%) | −324.0 | −324.0 | 8.10 |
| TP53 SRX19538268 | U2OS Bone | 381 / 9217 (4.1%) | 103 / 92170 (0.1%) | −296.5 | −293.4 | 36.99 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 976 / 9217 (10.6%) | 2053 / 92170 (2.2%) | −289.7 | −286.5 | 4.75 |
| TP53 SRX19538274 | U2OS Bone | 377 / 9217 (4.1%) | 109 / 92170 (0.1%) | −289.0 | −285.9 | 34.59 |
| TP53 SRX19538276 | U2OS Bone | 376 / 9217 (4.1%) | 118 / 92170 (0.1%) | −282.7 | −279.6 | 31.86 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 383 / 9217 (4.2%) | 130 / 92170 (0.1%) | −282.5 | −279.4 | 29.46 |
| TP53 SRX19538280 | Osteoblasts Bone | 367 / 9217 (4.0%) | 120 / 92170 (0.1%) | −273.2 | −270.1 | 30.58 |
| TP53 SRX19538269 | U2OS Bone | 417 / 9217 (4.5%) | 236 / 92170 (0.3%) | −263.3 | −260.3 | 17.67 |
| TP53 SRX19538267 | U2OS Bone | 336 / 9217 (3.6%) | 91 / 92170 (0.1%) | −261.2 | −258.2 | 36.92 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 519 / 9217 (5.6%) | 510 / 92170 (0.6%) | −258.2 | −255.2 | 10.18 |
| TP53 SRX19538281 | Osteoblasts Bone | 380 / 9217 (4.1%) | 175 / 92170 (0.2%) | −257.0 | −254.0 | 21.71 |
| TP53 SRX19538275 | U2OS Bone | 339 / 9217 (3.7%) | 105 / 92170 (0.1%) | −255.6 | −252.6 | 32.29 |
| BRD4 SRX736204 | 90-8TL Neural | 814 / 9217 (8.8%) | 1600 / 92170 (1.7%) | −255.1 | −252.1 | 5.09 |
| TP53 SRX19538273 | U2OS Bone | 332 / 9217 (3.6%) | 98 / 92170 (0.1%) | −253.1 | −250.2 | 33.88 |
| IRF3 SRX11453858 | Hep G2 Liver | 293 / 9217 (3.2%) | 49 / 92170 (0.1%) | −249.1 | −246.2 | 59.80 |
| TP53 SRX19538270 | U2OS Bone | 388 / 9217 (4.2%) | 233 / 92170 (0.3%) | −239.6 | −236.6 | 16.65 |
| HIF1A SRX20663235 | HK-2 Kidney | 362 / 9217 (3.9%) | 187 / 92170 (0.2%) | −235.8 | −232.8 | 19.36 |
| IRF3 SRX11453861 | Hep G2 Liver | 263 / 9217 (2.9%) | 45 / 92170 (0.0%) | −222.7 | −219.8 | 58.44 |
| TP53 SRX19538271 | U2OS Bone | 528 / 9217 (5.7%) | 695 / 92170 (0.8%) | −221.6 | −218.7 | 7.60 |
| TP53 SRX19538282 | Osteoblasts Bone | 329 / 9217 (3.6%) | 172 / 92170 (0.2%) | −213.3 | −210.4 | 19.13 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 994 / 9217 (10.8%) | 2862 / 92170 (3.1%) | −210.9 | −208.0 | 3.47 |
| AR SRX10820653 | LNCAP Prostate | 289 / 9217 (3.1%) | 107 / 92170 (0.1%) | −208.1 | −205.2 | 27.01 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 456 / 9217 (4.9%) | 542 / 92170 (0.6%) | −203.6 | −200.7 | 8.41 |
| PBX4 SRX2731658 | PC-3 Prostate | 468 / 9217 (5.1%) | 14322 / 92170 (15.5%) | −202.2 | −199.3 | 0.33 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 645 / 9217 (7.0%) | 1283 / 92170 (1.4%) | −198.7 | −195.8 | 5.03 |
| KAT6A SRX20971022 | Fibroblasts Others | 237 / 9217 (2.6%) | 49 / 92170 (0.1%) | −194.3 | −191.5 | 48.37 |
| AGO2 SRX4708039 | Hep G2 Liver | 1195 / 9217 (13.0%) | 4237 / 92170 (4.6%) | −192.3 | −189.4 | 2.82 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 830 / 9217 (9.0%) | 2276 / 92170 (2.5%) | −185.4 | −182.5 | 3.65 |
| AR SRX10820651 | LNCAP Prostate | 291 / 9217 (3.2%) | 164 / 92170 (0.2%) | −183.7 | −180.9 | 17.74 |
| TP53 SRX19538272 | U2OS Bone | 435 / 9217 (4.7%) | 635 / 92170 (0.7%) | −169.9 | −167.1 | 6.85 |
| FOS SRX150477 | MCF 10A Breast | 325 / 9217 (3.5%) | 10735 / 92170 (11.6%) | −160.3 | −157.5 | 0.30 |
| FOS SRX150478 | MCF 10A Breast | 351 / 9217 (3.8%) | 11040 / 92170 (12.0%) | −156.6 | −153.8 | 0.32 |
| YAP1 SRX757325 | H2052 Lung | 375 / 9217 (4.1%) | 11150 / 92170 (12.1%) | −148.2 | −145.4 | 0.34 |
| Epitope tags SRX10549776 | K-562 Blood | 869 / 9217 (9.4%) | 2933 / 92170 (3.2%) | −147.9 | −145.1 | 2.96 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 382 / 9217 (4.1%) | 587 / 92170 (0.6%) | −143.7 | −140.9 | 6.51 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 201 / 9217 (2.2%) | 81 / 92170 (0.1%) | −141.3 | −138.5 | 24.81 |
| STAT5B SRX831881 | CD8+ T cells Blood | 201 / 9217 (2.2%) | 82 / 92170 (0.1%) | −140.8 | −138.0 | 24.51 |
| YAP1 SRX757326 | H2052 Lung | 319 / 9217 (3.5%) | 9956 / 92170 (10.8%) | −138.8 | −136.0 | 0.32 |
| FOXA1 SRX176862 | MCF-7 Breast | 186 / 9217 (2.0%) | 7635 / 92170 (8.3%) | −136.7 | −133.9 | 0.24 |
| 5-mC SRX882970 | LNCAP Prostate | 1663 / 9217 (18.0%) | 8449 / 92170 (9.2%) | −136.5 | −133.8 | 1.97 |
| FOS SRX4192880 | MCF 10A Breast | 249 / 9217 (2.7%) | 8711 / 92170 (9.5%) | −135.9 | −133.2 | 0.29 |
| NFYB SRX16608147 | HeLa Uterus | 209 / 9217 (2.3%) | 111 / 92170 (0.1%) | −134.7 | −132.0 | 18.83 |
| RUNX1 SRX2513054 | 293 Kidney | 1836 / 9217 (19.9%) | 9842 / 92170 (10.7%) | −132.6 | −129.8 | 1.87 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 852 / 9217 (9.2%) | 3052 / 92170 (3.3%) | −132.4 | −129.7 | 2.79 |
| FOXA1 SRX4815198 | MCF-7 Breast | 551 / 9217 (6.0%) | 13226 / 92170 (14.3%) | −132.2 | −129.5 | 0.42 |
| BMI1 SRX644729 | 293 Kidney | 196 / 9217 (2.1%) | 91 / 92170 (0.1%) | −132.0 | −129.3 | 21.54 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 353 / 9217 (3.8%) | 10249 / 92170 (11.1%) | −131.3 | −128.6 | 0.34 |
| 5-mC SRX882968 | LNCAP Prostate | 1631 / 9217 (17.7%) | 8344 / 92170 (9.1%) | −131.2 | −128.6 | 1.95 |
| FOXA1 SRX176863 | MCF-7 Breast | 174 / 9217 (1.9%) | 7253 / 92170 (7.9%) | −131.0 | −128.3 | 0.24 |
| KAT7 SRX101303 | RKO Digestive tract | 817 / 9217 (8.9%) | 2864 / 92170 (3.1%) | −130.9 | −128.3 | 2.85 |
| BRD1 SRX286203 | RKO Digestive tract | 716 / 9217 (7.8%) | 2294 / 92170 (2.5%) | −130.3 | −127.7 | 3.12 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 178 / 9217 (1.9%) | 63 / 92170 (0.1%) | −129.7 | −127.0 | 28.25 |
| AGO2 SRX6783958 | Hep G2 Liver | 751 / 9217 (8.1%) | 2544 / 92170 (2.8%) | −126.4 | −123.8 | 2.95 |
| AGO2 SRX6783957 | Hep G2 Liver | 758 / 9217 (8.2%) | 2587 / 92170 (2.8%) | −126.2 | −123.5 | 2.93 |
| ESR1 SRX371478 | MCF-7 Breast | 196 / 9217 (2.1%) | 7467 / 92170 (8.1%) | −125.2 | −122.6 | 0.26 |
| FOXA1 SRX3931044 | MCF-7 Breast | 350 / 9217 (3.8%) | 9991 / 92170 (10.8%) | −125.0 | −122.3 | 0.35 |
| FOXA1 SRX4815197 | MCF-7 Breast | 408 / 9217 (4.4%) | 10870 / 92170 (11.8%) | −124.8 | −122.1 | 0.38 |
| ESR1 SRX371469 | MCF-7 Breast | 153 / 9217 (1.7%) | 6668 / 92170 (7.2%) | −124.4 | −121.8 | 0.23 |
| BRPF3 SRX796084 | RKO Digestive tract | 894 / 9217 (9.7%) | 3444 / 92170 (3.7%) | −123.5 | −120.9 | 2.60 |
| ESR1 SRX7624157 | MCF-7 Breast | 432 / 9217 (4.7%) | 11182 / 92170 (12.1%) | −123.5 | −120.9 | 0.39 |
| FOXA1 SRX1161177 | MCF-7 Breast | 149 / 9217 (1.6%) | 6532 / 92170 (7.1%) | −122.2 | −119.6 | 0.23 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 392 / 9217 (4.3%) | 768 / 92170 (0.8%) | −121.5 | −118.8 | 5.10 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1184 / 9217 (12.8%) | 5401 / 92170 (5.9%) | −120.6 | −118.0 | 2.19 |
| GATA3 SRX190239 | MCF-7 Breast | 237 / 9217 (2.6%) | 8023 / 92170 (8.7%) | −120.5 | −117.9 | 0.30 |
| ESR1 SRX4367193 | MCF-7 Breast | 558 / 9217 (6.1%) | 12839 / 92170 (13.9%) | −119.0 | −116.4 | 0.43 |
| MEAF6 DRX234811 | 293 Kidney | 987 / 9217 (10.7%) | 4127 / 92170 (4.5%) | −118.3 | −115.7 | 2.39 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 186 / 9217 (2.0%) | 7076 / 92170 (7.7%) | −118.1 | −115.5 | 0.26 |
| ESR1 SRX371479 | MCF-7 Breast | 140 / 9217 (1.5%) | 6219 / 92170 (6.7%) | −117.3 | −114.7 | 0.23 |
| 5-mC SRX882965 | LNCAP Prostate | 1332 / 9217 (14.5%) | 6511 / 92170 (7.1%) | −117.2 | −114.6 | 2.05 |
| LEO1 SRX1873456 | SEM Blood | 855 / 9217 (9.3%) | 3318 / 92170 (3.6%) | −116.4 | −113.8 | 2.58 |
| FOXA1 SRX1161175 | MCF-7 Breast | 108 / 9217 (1.2%) | 5567 / 92170 (6.0%) | −116.2 | −113.6 | 0.19 |
| FOXA1 SRX1161173 | MCF-7 Breast | 117 / 9217 (1.3%) | 5729 / 92170 (6.2%) | −115.7 | −113.1 | 0.20 |
| FOS SRX150517 | MCF 10A Breast | 291 / 9217 (3.2%) | 8741 / 92170 (9.5%) | −115.4 | −112.8 | 0.33 |
| FOXA1 SRX371481 | MCF-7 Breast | 169 / 9217 (1.8%) | 6680 / 92170 (7.2%) | −115.0 | −112.5 | 0.25 |
| ESR1 SRX194569 | MCF-7 Breast | 165 / 9217 (1.8%) | 6606 / 92170 (7.2%) | −115.0 | −112.4 | 0.25 |
| ESR1 SRX20282961 | MCF-7 Breast | 207 / 9217 (2.2%) | 7335 / 92170 (8.0%) | −114.7 | −112.1 | 0.28 |
| BRPF3 SRX796086 | RKO Digestive tract | 842 / 9217 (9.1%) | 3269 / 92170 (3.5%) | −114.5 | −112.0 | 2.58 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 194 / 9217 (2.1%) | 7076 / 92170 (7.7%) | −113.7 | −111.2 | 0.27 |
| FOXA1 SRX371483 | MCF-7 Breast | 185 / 9217 (2.0%) | 6917 / 92170 (7.5%) | −113.5 | −110.9 | 0.27 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 391 / 9217 (4.2%) | 824 / 92170 (0.9%) | −113.4 | −110.9 | 4.75 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 239 / 9217 (2.6%) | 7832 / 92170 (8.5%) | −113.4 | −110.9 | 0.31 |
| ESR1 SRX371476 | MCF-7 Breast | 113 / 9217 (1.2%) | 5572 / 92170 (6.0%) | −112.9 | −110.4 | 0.20 |
| CDK9 SRX7366783 | MCF-7 Breast | 179 / 9217 (1.9%) | 102 / 92170 (0.1%) | −112.6 | −110.1 | 17.55 |
| TLE3 SRX4815191 | MCF-7 Breast | 158 / 9217 (1.7%) | 6395 / 92170 (6.9%) | −112.2 | −109.7 | 0.25 |
| ESR1 SRX371467 | MCF-7 Breast | 170 / 9217 (1.8%) | 6610 / 92170 (7.2%) | −112.1 | −109.6 | 0.26 |
| ESR1 SRX176860 | MCF-7 Breast | 281 / 9217 (3.0%) | 8469 / 92170 (9.2%) | −112.0 | −109.5 | 0.33 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 296 / 9217 (3.2%) | 8689 / 92170 (9.4%) | −111.6 | −109.1 | 0.34 |
| BRPF3 SRX796085 | RKO Digestive tract | 623 / 9217 (6.8%) | 2021 / 92170 (2.2%) | −111.0 | −108.5 | 3.08 |
| FOXA1 SRX371482 | MCF-7 Breast | 251 / 9217 (2.7%) | 7952 / 92170 (8.6%) | −111.0 | −108.5 | 0.32 |
| ESR1 SRX7624156 | MCF-7 Breast | 279 / 9217 (3.0%) | 8390 / 92170 (9.1%) | −110.6 | −108.1 | 0.33 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1003 / 9217 (10.9%) | 4380 / 92170 (4.8%) | −110.6 | −108.1 | 2.29 |
| ESR1 SRX371471 | ZR-75-1 Breast | 182 / 9217 (2.0%) | 6752 / 92170 (7.3%) | −109.9 | −107.4 | 0.27 |
| SSRP1 SRX3436567 | HT-1080 Bone | 267 / 9217 (2.9%) | 360 / 92170 (0.4%) | −109.8 | −107.3 | 7.42 |
| FOXA1 SRX1161176 | MCF-7 Breast | 159 / 9217 (1.7%) | 6322 / 92170 (6.9%) | −109.2 | −106.8 | 0.25 |
| ESR1 SRX176861 | MCF-7 Breast | 292 / 9217 (3.2%) | 8526 / 92170 (9.3%) | −108.6 | −106.2 | 0.34 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 162 / 9217 (1.8%) | 6357 / 92170 (6.9%) | −108.6 | −106.2 | 0.25 |
| ESR1 SRX20282960 | MCF-7 Breast | 194 / 9217 (2.1%) | 6912 / 92170 (7.5%) | −108.3 | −105.9 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 761 / 9217 (8.3%) | 2874 / 92170 (3.1%) | −107.9 | −105.5 | 2.65 |
| FOS SRX150476 | MCF 10A Breast | 311 / 9217 (3.4%) | 8800 / 92170 (9.5%) | −107.8 | −105.4 | 0.35 |
| ESR1 SRX371470 | ZR-75-1 Breast | 152 / 9217 (1.6%) | 6150 / 92170 (6.7%) | −107.7 | −105.3 | 0.25 |
| CIC SRX13262055 | Astrocytes Neural | 1667 / 9217 (18.1%) | 9271 / 92170 (10.1%) | −107.0 | −104.6 | 1.80 |
| ESR1 SRX10365536 | MCF-7 Breast | 73 / 9217 (0.8%) | 4582 / 92170 (5.0%) | −106.7 | −104.3 | 0.16 |
| FOXA1 SRX1787653 | MCF-7 Breast | 130 / 9217 (1.4%) | 5705 / 92170 (6.2%) | −106.4 | −103.9 | 0.23 |
| ESR1 SRX194572 | MCF-7 Breast | 100 / 9217 (1.1%) | 5119 / 92170 (5.6%) | −106.1 | −103.7 | 0.20 |
| JUNB SRX8488088 | SUM 229PE Breast | 345 / 9217 (3.7%) | 9253 / 92170 (10.0%) | −105.8 | −103.4 | 0.37 |
| ESR1 SRX1531791 | MCF-7 Breast | 163 / 9217 (1.8%) | 6286 / 92170 (6.8%) | −105.7 | −103.3 | 0.26 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 309 / 9217 (3.4%) | 540 / 92170 (0.6%) | −105.3 | −102.8 | 5.72 |
| SREBF2 SRX5359048 | HCC70 Breast | 967 / 9217 (10.5%) | 4246 / 92170 (4.6%) | −105.0 | −102.6 | 2.28 |
| ARID1A SRX5089376 | MCF-7 Breast | 142 / 9217 (1.5%) | 5888 / 92170 (6.4%) | −105.0 | −102.6 | 0.24 |
| MEAF6 DRX300417 | 293 Kidney | 882 / 9217 (9.6%) | 3689 / 92170 (4.0%) | −105.0 | −102.6 | 2.39 |
| ESR1 SRX20282939 | MCF-7 Breast | 201 / 9217 (2.2%) | 6920 / 92170 (7.5%) | −104.9 | −102.5 | 0.29 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 335 / 9217 (3.6%) | 650 / 92170 (0.7%) | −104.6 | −102.2 | 5.15 |
| FOXA1 SRX1161174 | MCF-7 Breast | 177 / 9217 (1.9%) | 6499 / 92170 (7.1%) | −104.6 | −102.2 | 0.27 |
| GATA3 SRX176864 | MCF-7 Breast | 115 / 9217 (1.2%) | 5369 / 92170 (5.8%) | −104.6 | −102.2 | 0.21 |
| CDK9 SRX7366781 | MCF-7 Breast | 164 / 9217 (1.8%) | 91 / 92170 (0.1%) | −104.2 | −101.8 | 18.02 |
| ESR1 SRX371468 | MCF-7 Breast | 104 / 9217 (1.1%) | 5126 / 92170 (5.6%) | −103.6 | −101.2 | 0.20 |
| FOXA1 SRX371480 | MCF-7 Breast | 110 / 9217 (1.2%) | 5227 / 92170 (5.7%) | −103.0 | −100.6 | 0.21 |
| Epitope tags DRX443510 | 293 Kidney | 836 / 9217 (9.1%) | 3429 / 92170 (3.7%) | −103.0 | −100.6 | 2.44 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 161 / 9217 (1.7%) | 6165 / 92170 (6.7%) | −103.0 | −100.6 | 0.26 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 630 / 9217 (6.8%) | 13193 / 92170 (14.3%) | −102.7 | −100.3 | 0.48 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 163 / 9217 (1.8%) | 6162 / 92170 (6.7%) | −101.7 | −99.3 | 0.26 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 229 / 9217 (2.5%) | 7275 / 92170 (7.9%) | −101.5 | −99.1 | 0.31 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1077 / 9217 (11.7%) | 5091 / 92170 (5.5%) | −100.6 | −98.3 | 2.12 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 270 / 9217 (2.9%) | 7908 / 92170 (8.6%) | −100.6 | −98.2 | 0.34 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 408 / 9217 (4.4%) | 9980 / 92170 (10.8%) | −100.1 | −97.7 | 0.41 |
| FOXA1 SRX028634 | MCF-7 Breast | 73 / 9217 (0.8%) | 4395 / 92170 (4.8%) | −99.9 | −97.6 | 0.17 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1089 / 9217 (11.8%) | 5193 / 92170 (5.6%) | −99.9 | −97.6 | 2.10 |
| RAC1 SRX10365541 | MCF-7 Breast | 80 / 9217 (0.9%) | 4525 / 92170 (4.9%) | −99.4 | −97.1 | 0.18 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 236 / 9217 (2.6%) | 7316 / 92170 (7.9%) | −99.3 | −96.9 | 0.32 |
| AR SRX1067071 | LHSAR Prostate | 373 / 9217 (4.0%) | 9435 / 92170 (10.2%) | −99.3 | −96.9 | 0.40 |
| ESR1 SRX20282954 | MCF-7 Breast | 199 / 9217 (2.2%) | 6689 / 92170 (7.3%) | −98.7 | −96.3 | 0.30 |
| RAC1 SRX10365543 | MCF-7 Breast | 82 / 9217 (0.9%) | 4536 / 92170 (4.9%) | −98.3 | −96.0 | 0.18 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 927 / 9217 (10.1%) | 4114 / 92170 (4.5%) | −98.3 | −96.0 | 2.25 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 123 / 9217 (1.3%) | 5321 / 92170 (5.8%) | −97.9 | −95.5 | 0.23 |
| FOXA1 SRX3923514 | MCF-7 Breast | 186 / 9217 (2.0%) | 6437 / 92170 (7.0%) | −97.8 | −95.5 | 0.29 |
| KMT2A SRX2323891 | 293 Kidney | 572 / 9217 (6.2%) | 1908 / 92170 (2.1%) | −97.7 | −95.4 | 3.00 |
| ESR1 SRX2943591 | MCF-7 Breast | 119 / 9217 (1.3%) | 5241 / 92170 (5.7%) | −97.7 | −95.4 | 0.23 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 73 / 9217 (0.8%) | 4319 / 92170 (4.7%) | −97.4 | −95.1 | 0.17 |
| JUN SRX17561461 | LPS141 Adipocyte | 271 / 9217 (2.9%) | 7804 / 92170 (8.5%) | −97.1 | −94.8 | 0.35 |
| NR2F2 SRX190293 | MCF-7 Breast | 191 / 9217 (2.1%) | 6493 / 92170 (7.0%) | −96.9 | −94.6 | 0.29 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 249 / 9217 (2.7%) | 7448 / 92170 (8.1%) | −96.9 | −94.6 | 0.33 |
| ESR1 SRX371475 | BT-474 Breast | 79 / 9217 (0.9%) | 4433 / 92170 (4.8%) | −96.8 | −94.5 | 0.18 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 185 / 9217 (2.0%) | 6384 / 92170 (6.9%) | −96.7 | −94.4 | 0.29 |
| FOXA1 SRX100454 | T-47D Breast | 248 / 9217 (2.7%) | 7410 / 92170 (8.0%) | −96.4 | −94.1 | 0.33 |
| GATA3 SRX5057632 | MCF-7 Breast | 110 / 9217 (1.2%) | 5032 / 92170 (5.5%) | −96.3 | −94.0 | 0.22 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 142 / 9217 (1.5%) | 5618 / 92170 (6.1%) | −96.3 | −94.0 | 0.25 |
| ESR1 SRX371477 | MCF-7 Breast | 83 / 9217 (0.9%) | 4495 / 92170 (4.9%) | −96.1 | −93.8 | 0.18 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 394 / 9217 (4.3%) | 989 / 92170 (1.1%) | −95.8 | −93.5 | 3.98 |
| ESR1 SRX10365532 | MCF-7 Breast | 86 / 9217 (0.9%) | 4545 / 92170 (4.9%) | −95.8 | −93.5 | 0.19 |
| ESR1 SRX20282940 | MCF-7 Breast | 198 / 9217 (2.1%) | 6574 / 92170 (7.1%) | −95.7 | −93.4 | 0.30 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 185 / 9217 (2.0%) | 6350 / 92170 (6.9%) | −95.6 | −93.4 | 0.29 |
| GATA3 SRX190194 | SK-N-SH Neural | 450 / 9217 (4.9%) | 10411 / 92170 (11.3%) | −95.5 | −93.2 | 0.43 |
| EP300 SRX176885 | MCF-7 Breast | 82 / 9217 (0.9%) | 4454 / 92170 (4.8%) | −95.5 | −93.2 | 0.18 |
| FOXA1 SRX3923517 | MCF-7 Breast | 122 / 9217 (1.3%) | 5227 / 92170 (5.7%) | −95.3 | −93.1 | 0.23 |
| ESR1 SRX371474 | BT-474 Breast | 71 / 9217 (0.8%) | 4221 / 92170 (4.6%) | −95.3 | −93.0 | 0.17 |
| FOS SRX4192879 | MCF 10A Breast | 217 / 9217 (2.4%) | 6868 / 92170 (7.5%) | −95.2 | −92.9 | 0.32 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 266 / 9217 (2.9%) | 437 / 92170 (0.5%) | −95.1 | −92.8 | 6.09 |
| FOXA1 SRX11222437 | MCF-7 Breast | 127 / 9217 (1.4%) | 5300 / 92170 (5.8%) | −94.7 | −92.4 | 0.24 |
| FOXA1 SRX028635 | MCF-7 Breast | 81 / 9217 (0.9%) | 4407 / 92170 (4.8%) | −94.5 | −92.2 | 0.18 |
| ESR1 SRX10365535 | MCF-7 Breast | 146 / 9217 (1.6%) | 5625 / 92170 (6.1%) | −94.1 | −91.8 | 0.26 |
| JUNB SRX4192882 | MCF 10A Breast | 141 / 9217 (1.5%) | 5535 / 92170 (6.0%) | −94.1 | −91.8 | 0.25 |
| FOXA1 SRX3931043 | MCF-7 Breast | 188 / 9217 (2.0%) | 6349 / 92170 (6.9%) | −94.0 | −91.7 | 0.30 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 648 / 9217 (7.0%) | 13055 / 92170 (14.2%) | −93.5 | −91.3 | 0.50 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1010 / 9217 (11.0%) | 4786 / 92170 (5.2%) | −93.5 | −91.2 | 2.11 |
| ESR1 SRX20282972 | MCF-7 Breast | 212 / 9217 (2.3%) | 6732 / 92170 (7.3%) | −93.4 | −91.2 | 0.31 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 259 / 9217 (2.8%) | 421 / 92170 (0.5%) | −93.4 | −91.1 | 6.15 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 149 / 9217 (1.6%) | 5655 / 92170 (6.1%) | −93.3 | −91.1 | 0.26 |
| FOXA1 SRX1787652 | MCF-7 Breast | 104 / 9217 (1.1%) | 4814 / 92170 (5.2%) | −92.9 | −90.6 | 0.22 |
| FOXA1 SRX5323843 | MCF-7 Breast | 86 / 9217 (0.9%) | 4455 / 92170 (4.8%) | −92.6 | −90.4 | 0.19 |
| FOXA1 SRX1787655 | MCF-7 Breast | 85 / 9217 (0.9%) | 4433 / 92170 (4.8%) | −92.6 | −90.3 | 0.19 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 126 / 9217 (1.4%) | 44 / 92170 (0.0%) | −92.3 | −90.0 | 28.64 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 174 / 9217 (1.9%) | 6049 / 92170 (6.6%) | −92.1 | −89.9 | 0.29 |
| ARID1A SRX5089379 | MCF-7 Breast | 188 / 9217 (2.0%) | 6283 / 92170 (6.8%) | −92.0 | −89.7 | 0.30 |
| JUN SRX4192884 | MCF 10A Breast | 152 / 9217 (1.6%) | 5661 / 92170 (6.1%) | −91.9 | −89.6 | 0.27 |
| ESR1 SRX2912055 | MCF-7 Breast | 57 / 9217 (0.6%) | 3820 / 92170 (4.1%) | −91.8 | −89.5 | 0.15 |
| ESR1 SRX330070 | MCF-7 Breast | 86 / 9217 (0.9%) | 4420 / 92170 (4.8%) | −91.5 | −89.3 | 0.19 |
| FOXA1 SRX11222442 | MCF-7 Breast | 125 / 9217 (1.4%) | 5161 / 92170 (5.6%) | −91.3 | −89.1 | 0.24 |
| ESR1 SRX20282973 | MCF-7 Breast | 234 / 9217 (2.5%) | 7019 / 92170 (7.6%) | −91.3 | −89.1 | 0.33 |
| MECOM SRX23677897 | HNT-34 Blood | 1134 / 9217 (12.3%) | 5724 / 92170 (6.2%) | −91.1 | −88.9 | 1.98 |
| PGR SRX1012655 | MCF-7 Breast | 110 / 9217 (1.2%) | 4865 / 92170 (5.3%) | −90.8 | −88.6 | 0.23 |
| FOXA1 SRX3923518 | MCF-7 Breast | 126 / 9217 (1.4%) | 5164 / 92170 (5.6%) | −90.8 | −88.6 | 0.24 |
| TLE3 SRX4815192 | MCF-7 Breast | 170 / 9217 (1.8%) | 5941 / 92170 (6.4%) | −90.8 | −88.6 | 0.29 |
| ETS1 SRX3033231 | HEYA8 Gonad | 188 / 9217 (2.0%) | 194 / 92170 (0.2%) | −90.8 | −88.6 | 9.69 |
| FOXA1 SRX3923516 | MCF-7 Breast | 134 / 9217 (1.5%) | 5298 / 92170 (5.7%) | −90.5 | −88.2 | 0.25 |
| FOXA1 SRX3923519 | MCF-7 Breast | 110 / 9217 (1.2%) | 4854 / 92170 (5.3%) | −90.4 | −88.2 | 0.23 |
| AR SRX1067070 | LHSAR Prostate | 486 / 9217 (5.3%) | 10707 / 92170 (11.6%) | −90.1 | −87.9 | 0.45 |
| MECOM SRX23677885 | HNT-34 Blood | 970 / 9217 (10.5%) | 4590 / 92170 (5.0%) | −89.9 | −87.7 | 2.11 |
| FOXA1 SRX11222441 | MCF-7 Breast | 149 / 9217 (1.6%) | 5542 / 92170 (6.0%) | −89.8 | −87.6 | 0.27 |
| FOXA1 SRX3931054 | MCF-7 Breast | 179 / 9217 (1.9%) | 6063 / 92170 (6.6%) | −89.8 | −87.6 | 0.30 |
| ESR1 SRX20282946 | MCF-7 Breast | 108 / 9217 (1.2%) | 4799 / 92170 (5.2%) | −89.8 | −87.6 | 0.23 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 489 / 9217 (5.3%) | 1551 / 92170 (1.7%) | −89.5 | −87.3 | 3.15 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 177 / 9217 (1.9%) | 6014 / 92170 (6.5%) | −89.4 | −87.2 | 0.29 |
| TRP47 SRX4548329 | THP-1 Blood | 1395 / 9217 (15.1%) | 7708 / 92170 (8.4%) | −89.4 | −87.2 | 1.81 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 289 / 9217 (3.1%) | 567 / 92170 (0.6%) | −89.3 | −87.1 | 5.10 |
| ESR1 SRX330069 | MCF-7 Breast | 110 / 9217 (1.2%) | 4823 / 92170 (5.2%) | −89.3 | −87.1 | 0.23 |
| ESR1 SRX330067 | MCF-7 Breast | 171 / 9217 (1.9%) | 5902 / 92170 (6.4%) | −89.0 | −86.8 | 0.29 |
| PTEN SRX5416007 | SMMC-7721 Liver | 988 / 9217 (10.7%) | 4740 / 92170 (5.1%) | −88.8 | −86.6 | 2.08 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 212 / 9217 (2.3%) | 6576 / 92170 (7.1%) | −88.8 | −86.6 | 0.32 |
| ESR1 SRX2943589 | MCF-7 Breast | 90 / 9217 (1.0%) | 4420 / 92170 (4.8%) | −88.7 | −86.6 | 0.20 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 127 / 9217 (1.4%) | 53 / 92170 (0.1%) | −88.6 | −86.4 | 23.96 |
| JUNB SRX10119386 | MCF 10A Breast | 175 / 9217 (1.9%) | 5951 / 92170 (6.5%) | −88.5 | −86.3 | 0.29 |
| FOXA1 SRX1787651 | MCF-7 Breast | 103 / 9217 (1.1%) | 4657 / 92170 (5.1%) | −88.2 | −86.0 | 0.22 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 446 / 9217 (4.8%) | 1334 / 92170 (1.4%) | −88.1 | −86.0 | 3.34 |
| AR SRX9469988 | LAPC-4 Prostate | 264 / 9217 (2.9%) | 7377 / 92170 (8.0%) | −88.0 | −85.8 | 0.36 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 482 / 9217 (5.2%) | 10562 / 92170 (11.5%) | −87.9 | −85.7 | 0.46 |
| ESR1 SRX3123829 | MCF-7 Breast | 102 / 9217 (1.1%) | 4627 / 92170 (5.0%) | −87.9 | −85.7 | 0.22 |
| FOXA1 SRX3931055 | MCF-7 Breast | 164 / 9217 (1.8%) | 5736 / 92170 (6.2%) | −87.7 | −85.5 | 0.29 |
| VGLL1 SRX24602130 | BT-20 Breast | 202 / 9217 (2.2%) | 6369 / 92170 (6.9%) | −87.6 | −85.4 | 0.32 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 946 / 9217 (10.3%) | 4476 / 92170 (4.9%) | −87.5 | −85.3 | 2.11 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 175 / 9217 (1.9%) | 5913 / 92170 (6.4%) | −87.3 | −85.2 | 0.30 |
| FOXA1 SRX11222438 | MCF-7 Breast | 98 / 9217 (1.1%) | 4532 / 92170 (4.9%) | −87.3 | −85.2 | 0.22 |
| KAT7 DRX234808 | 293 Kidney | 437 / 9217 (4.7%) | 1298 / 92170 (1.4%) | −87.1 | −85.0 | 3.37 |
| FOXA1 SRX5323845 | MCF-7 Breast | 59 / 9217 (0.6%) | 3735 / 92170 (4.1%) | −87.0 | −84.9 | 0.16 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 861 / 9217 (9.3%) | 3906 / 92170 (4.2%) | −86.9 | −84.8 | 2.20 |
| EP300 SRX1012648 | MCF-7 Breast | 84 / 9217 (0.9%) | 4240 / 92170 (4.6%) | −86.6 | −84.4 | 0.20 |
| ESR1 SRX20282955 | MCF-7 Breast | 209 / 9217 (2.3%) | 6450 / 92170 (7.0%) | −86.5 | −84.3 | 0.32 |
| MECOM SRX23677896 | HNT-34 Blood | 1153 / 9217 (12.5%) | 5981 / 92170 (6.5%) | −86.4 | −84.2 | 1.93 |
| CDYL2 SRX8321653 | MCF-7 Breast | 991 / 9217 (10.8%) | 4821 / 92170 (5.2%) | −86.3 | −84.1 | 2.06 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 333 / 9217 (3.6%) | 8349 / 92170 (9.1%) | −86.0 | −83.8 | 0.40 |
| BMI1 SRX7196721 | SF8628 Neural | 933 / 9217 (10.1%) | 4421 / 92170 (4.8%) | −85.9 | −83.8 | 2.11 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 980 / 9217 (10.6%) | 4752 / 92170 (5.2%) | −85.9 | −83.8 | 2.06 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 187 / 9217 (2.0%) | 6062 / 92170 (6.6%) | −85.7 | −83.6 | 0.31 |
| MECOM SRX23677884 | HNT-34 Blood | 941 / 9217 (10.2%) | 4485 / 92170 (4.9%) | −85.7 | −83.5 | 2.10 |
| ESR1 SRX1012632 | MCF-7 Breast | 87 / 9217 (0.9%) | 4269 / 92170 (4.6%) | −85.6 | −83.5 | 0.20 |
| FOXA1 SRX3923515 | MCF-7 Breast | 103 / 9217 (1.1%) | 4581 / 92170 (5.0%) | −85.6 | −83.5 | 0.22 |
| FOXA1 SRX3923511 | MCF-7 Breast | 65 / 9217 (0.7%) | 3823 / 92170 (4.1%) | −85.6 | −83.5 | 0.17 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 185 / 9217 (2.0%) | 6021 / 92170 (6.5%) | −85.5 | −83.4 | 0.31 |
| ESR1 SRX4367192 | MCF-7 Breast | 414 / 9217 (4.5%) | 9503 / 92170 (10.3%) | −85.3 | −83.2 | 0.44 |
| ESR1 SRX1012629 | MCF-7 Breast | 118 / 9217 (1.3%) | 4848 / 92170 (5.3%) | −85.2 | −83.1 | 0.24 |
| CEBPB SRX150632 | HeLa Uterus | 465 / 9217 (5.0%) | 10209 / 92170 (11.1%) | −85.0 | −82.9 | 0.46 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 354 / 9217 (3.8%) | 8611 / 92170 (9.3%) | −84.6 | −82.5 | 0.41 |
| SMARCA4 SRX5212366 | Mel270 Others | 277 / 9217 (3.0%) | 7455 / 92170 (8.1%) | −84.6 | −82.5 | 0.37 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 651 / 9217 (7.1%) | 12709 / 92170 (13.8%) | −84.6 | −82.4 | 0.51 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 223 / 9217 (2.4%) | 6609 / 92170 (7.2%) | −84.5 | −82.4 | 0.34 |
| TP53 SRX396254 | Fibroblasts Others | 476 / 9217 (5.2%) | 1543 / 92170 (1.7%) | −84.5 | −82.4 | 3.08 |
| GATA3 SRX6712581 | MCF-7 Breast | 165 / 9217 (1.8%) | 5649 / 92170 (6.1%) | −84.4 | −82.2 | 0.29 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 90 / 9217 (1.0%) | 4288 / 92170 (4.7%) | −84.3 | −82.1 | 0.21 |
| ESR1 SRX3110725 | MCF-7 Breast | 177 / 9217 (1.9%) | 5840 / 92170 (6.3%) | −84.0 | −81.9 | 0.30 |
| JUN SRX883584 | MDA-MB-231 Breast | 321 / 9217 (3.5%) | 8090 / 92170 (8.8%) | −83.8 | −81.7 | 0.40 |
| ARID1A SRX5089385 | MCF-7 Breast | 147 / 9217 (1.6%) | 5319 / 92170 (5.8%) | −83.8 | −81.6 | 0.28 |
| SMARCA4 SRX5212362 | Mel270 Others | 357 / 9217 (3.9%) | 8616 / 92170 (9.3%) | −83.7 | −81.6 | 0.41 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 420 / 9217 (4.6%) | 1248 / 92170 (1.4%) | −83.7 | −81.6 | 3.37 |
| ESR1 SRX10365533 | MCF-7 Breast | 90 / 9217 (1.0%) | 4260 / 92170 (4.6%) | −83.3 | −81.2 | 0.21 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 901 / 9217 (9.8%) | 4260 / 92170 (4.6%) | −83.3 | −81.2 | 2.12 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 196 / 9217 (2.1%) | 6124 / 92170 (6.6%) | −83.2 | −81.1 | 0.32 |
| EP300 SRX176883 | MCF-7 Breast | 85 / 9217 (0.9%) | 4154 / 92170 (4.5%) | −83.1 | −81.0 | 0.20 |
| ZFX SRX7805372 | 293 Kidney | 834 / 9217 (9.0%) | 3807 / 92170 (4.1%) | −83.1 | −81.0 | 2.19 |
| ESR1 SRX20282971 | MCF-7 Breast | 197 / 9217 (2.1%) | 6136 / 92170 (6.7%) | −83.0 | −80.9 | 0.32 |
| ESR1 SRX10365558 | MCF-7 Breast | 133 / 9217 (1.4%) | 5044 / 92170 (5.5%) | −82.8 | −80.7 | 0.26 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 64 / 9217 (0.7%) | 3720 / 92170 (4.0%) | −82.7 | −80.7 | 0.17 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 661 / 9217 (7.2%) | 2679 / 92170 (2.9%) | −82.6 | −80.5 | 2.47 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 196 / 9217 (2.1%) | 6096 / 92170 (6.6%) | −82.4 | −80.3 | 0.32 |
| FOXA1 SRX5323829 | T-47D Breast | 113 / 9217 (1.2%) | 4666 / 92170 (5.1%) | −82.3 | −80.2 | 0.24 |
| ARID1A SRX5089391 | MCF-7 Breast | 106 / 9217 (1.2%) | 4534 / 92170 (4.9%) | −82.2 | −80.1 | 0.23 |
| JADE3 DRX300415 | 293 Kidney | 823 / 9217 (8.9%) | 3752 / 92170 (4.1%) | −82.0 | −79.9 | 2.19 |
| FOXA1 SRX1787654 | MCF-7 Breast | 64 / 9217 (0.7%) | 3697 / 92170 (4.0%) | −82.0 | −79.9 | 0.17 |
| JUNB SRX10119383 | MCF 10A Breast | 140 / 9217 (1.5%) | 5135 / 92170 (5.6%) | −81.9 | −79.8 | 0.27 |
| FOXA1 SRX100506 | Hep G2 Liver | 280 / 9217 (3.0%) | 7403 / 92170 (8.0%) | −81.9 | −79.8 | 0.38 |
| FOXA1 SRX3931032 | MCF-7 Breast | 113 / 9217 (1.2%) | 4649 / 92170 (5.0%) | −81.8 | −79.8 | 0.24 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 181 / 9217 (2.0%) | 5828 / 92170 (6.3%) | −81.7 | −79.6 | 0.31 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 189 / 9217 (2.1%) | 5958 / 92170 (6.5%) | −81.6 | −79.6 | 0.32 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 198 / 9217 (2.1%) | 6106 / 92170 (6.6%) | −81.6 | −79.6 | 0.32 |
| FOXA1 SRX3931033 | MCF-7 Breast | 126 / 9217 (1.4%) | 4879 / 92170 (5.3%) | −81.6 | −79.5 | 0.26 |
| FOXA1 SRX5203307 | MCF-7 Breast | 48 / 9217 (0.5%) | 3340 / 92170 (3.6%) | −81.6 | −79.5 | 0.14 |
| SMARCA4 SRX5212357 | Mel270 Others | 304 / 9217 (3.3%) | 7749 / 92170 (8.4%) | −81.4 | −79.4 | 0.39 |
| ESR1 SRX5323873 | MCF-7 Breast | 255 / 9217 (2.8%) | 7004 / 92170 (7.6%) | −81.4 | −79.3 | 0.36 |
| ESR1 SRX1012633 | MCF-7 Breast | 98 / 9217 (1.1%) | 4354 / 92170 (4.7%) | −81.4 | −79.3 | 0.23 |
| FOXA1 SRX5323846 | MCF-7 Breast | 70 / 9217 (0.8%) | 3804 / 92170 (4.1%) | −81.3 | −79.2 | 0.18 |
| Epitope tags SRX10549778 | K-562 Blood | 597 / 9217 (6.5%) | 2301 / 92170 (2.5%) | −81.3 | −79.2 | 2.59 |
| ESR1 SRX330068 | MCF-7 Breast | 90 / 9217 (1.0%) | 4196 / 92170 (4.6%) | −81.2 | −79.1 | 0.21 |
| FOXA1 SRX5203303 | MCF-7 Breast | 60 / 9217 (0.7%) | 3591 / 92170 (3.9%) | −81.1 | −79.1 | 0.17 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 199 / 9217 (2.2%) | 6095 / 92170 (6.6%) | −80.8 | −78.7 | 0.33 |
| FOSL2 SRX190296 | SK-N-SH Neural | 282 / 9217 (3.1%) | 7389 / 92170 (8.0%) | −80.7 | −78.7 | 0.38 |
| EP300 SRX1012643 | MCF-7 Breast | 65 / 9217 (0.7%) | 3684 / 92170 (4.0%) | −80.7 | −78.6 | 0.18 |
| FOXA2 SRX3230382 | Hep G2 Liver | 289 / 9217 (3.1%) | 7492 / 92170 (8.1%) | −80.6 | −78.5 | 0.39 |
| ESR1 SRX4451213 | MCF-7 Breast | 211 / 9217 (2.3%) | 6277 / 92170 (6.8%) | −80.5 | −78.5 | 0.34 |
| FOXA1 SRX1447317 | MCF-7 Breast | 133 / 9217 (1.4%) | 4962 / 92170 (5.4%) | −80.4 | −78.3 | 0.27 |
| ESR1 SRX2881002 | MCF-7 Breast | 202 / 9217 (2.2%) | 6128 / 92170 (6.6%) | −80.3 | −78.3 | 0.33 |
| FOXA1 SRX5203294 | MCF-7 Breast | 50 / 9217 (0.5%) | 3348 / 92170 (3.6%) | −80.2 | −78.2 | 0.15 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 140 / 9217 (1.5%) | 5079 / 92170 (5.5%) | −80.2 | −78.1 | 0.28 |
| JUNB SRX8488089 | SUM 229PE Breast | 212 / 9217 (2.3%) | 6273 / 92170 (6.8%) | −80.0 | −77.9 | 0.34 |
| ERG SRX063922 | K-562 Blood | 839 / 9217 (9.1%) | 3913 / 92170 (4.2%) | −79.7 | −77.7 | 2.14 |
| SSRP1 SRX3436566 | HT-1080 Bone | 185 / 9217 (2.0%) | 233 / 92170 (0.3%) | −79.6 | −77.5 | 7.94 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 300 / 9217 (3.3%) | 7615 / 92170 (8.3%) | −79.4 | −77.4 | 0.39 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 586 / 9217 (6.4%) | 2266 / 92170 (2.5%) | −79.3 | −77.3 | 2.59 |
| ESR1 SRX20282938 | MCF-7 Breast | 164 / 9217 (1.8%) | 5463 / 92170 (5.9%) | −79.3 | −77.3 | 0.30 |
| EP300 SRX1012644 | MCF-7 Breast | 85 / 9217 (0.9%) | 4042 / 92170 (4.4%) | −79.2 | −77.2 | 0.21 |
| ESR1 SRX2881000 | MCF-7 Breast | 185 / 9217 (2.0%) | 5809 / 92170 (6.3%) | −79.2 | −77.2 | 0.32 |
| ZEB1 SRX13298925 | MCF-7 Breast | 125 / 9217 (1.4%) | 4786 / 92170 (5.2%) | −79.2 | −77.1 | 0.26 |
| JUNB SRX8488073 | SUM 229PE Breast | 399 / 9217 (4.3%) | 9041 / 92170 (9.8%) | −79.1 | −77.0 | 0.44 |
| ESR1 SRX1469949 | MCF-7 Breast | 116 / 9217 (1.3%) | 4618 / 92170 (5.0%) | −79.0 | −76.9 | 0.25 |
| NR3C1 SRX19024866 | MCF-7 Breast | 64 / 9217 (0.7%) | 3615 / 92170 (3.9%) | −78.9 | −76.9 | 0.18 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 412 / 9217 (4.5%) | 9214 / 92170 (10.0%) | −78.8 | −76.8 | 0.45 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 312 / 9217 (3.4%) | 7770 / 92170 (8.4%) | −78.8 | −76.7 | 0.40 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 174 / 9217 (1.9%) | 5614 / 92170 (6.1%) | −78.7 | −76.7 | 0.31 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 846 / 9217 (9.2%) | 3983 / 92170 (4.3%) | −78.7 | −76.7 | 2.12 |
| ESR1 SRX20282953 | MCF-7 Breast | 171 / 9217 (1.9%) | 5554 / 92170 (6.0%) | −78.5 | −76.5 | 0.31 |
| SS18 SRX3468047 | Fibroblasts Others | 538 / 9217 (5.8%) | 10937 / 92170 (11.9%) | −78.4 | −76.4 | 0.49 |
| ARID1A SRX5089388 | MCF-7 Breast | 101 / 9217 (1.1%) | 4325 / 92170 (4.7%) | −78.4 | −76.4 | 0.23 |
| FOXA1 SRX1447316 | MCF-7 Breast | 83 / 9217 (0.9%) | 3976 / 92170 (4.3%) | −78.4 | −76.3 | 0.21 |
| TCF12 SRX190356 | SK-N-SH Neural | 571 / 9217 (6.2%) | 11376 / 92170 (12.3%) | −78.4 | −76.3 | 0.50 |
| SMARCA4 SRX5212371 | Mel270 Others | 304 / 9217 (3.3%) | 7628 / 92170 (8.3%) | −78.2 | −76.2 | 0.40 |
| FOXA1 SRX3931056 | MCF-7 Breast | 122 / 9217 (1.3%) | 4698 / 92170 (5.1%) | −78.2 | −76.2 | 0.26 |
| FOXA2 SRX100448 | Hep G2 Liver | 239 / 9217 (2.6%) | 6639 / 92170 (7.2%) | −78.2 | −76.1 | 0.36 |
| Epitope tags SRX10715360 | HCB1 Blood | 611 / 9217 (6.6%) | 2442 / 92170 (2.6%) | −78.1 | −76.1 | 2.50 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 421 / 9217 (4.6%) | 9315 / 92170 (10.1%) | −78.1 | −76.1 | 0.45 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 664 / 9217 (7.2%) | 2779 / 92170 (3.0%) | −78.1 | −76.1 | 2.39 |
| FOXA1 SRX15430999 | T-47D Breast | 243 / 9217 (2.6%) | 6694 / 92170 (7.3%) | −78.0 | −76.0 | 0.36 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 392 / 9217 (4.3%) | 1165 / 92170 (1.3%) | −78.0 | −76.0 | 3.36 |
| NCOA1 SRX036638 | U2OS Bone | 113 / 9217 (1.2%) | 49 / 92170 (0.1%) | −78.0 | −76.0 | 23.06 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 141 / 9217 (1.5%) | 5022 / 92170 (5.4%) | −77.8 | −75.8 | 0.28 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 121 / 9217 (1.3%) | 4671 / 92170 (5.1%) | −77.8 | −75.8 | 0.26 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 139 / 9217 (1.5%) | 4985 / 92170 (5.4%) | −77.8 | −75.8 | 0.28 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 611 / 9217 (6.6%) | 11878 / 92170 (12.9%) | −77.7 | −75.7 | 0.51 |
| TFAP2C SRX128099 | MCF-7 Breast | 190 / 9217 (2.1%) | 5838 / 92170 (6.3%) | −77.6 | −75.6 | 0.33 |
| TEAD1 SRX3401272 | MCF-7 Breast | 160 / 9217 (1.7%) | 5338 / 92170 (5.8%) | −77.6 | −75.6 | 0.30 |
| GATA3 SRX5457550 | MCF-7 Breast | 244 / 9217 (2.6%) | 6690 / 92170 (7.3%) | −77.5 | −75.5 | 0.36 |
| TFAP2C SRX018833 | MCF-7 Breast | 191 / 9217 (2.1%) | 5847 / 92170 (6.3%) | −77.5 | −75.5 | 0.33 |
| ESR1 SRX2513521 | MCF-7 Breast | 95 / 9217 (1.0%) | 4173 / 92170 (4.5%) | −77.2 | −75.2 | 0.23 |
| CDK9 SRX7366779 | MCF-7 Breast | 128 / 9217 (1.4%) | 82 / 92170 (0.1%) | −77.2 | −75.2 | 15.61 |
| ESR1 SRX4451212 | MCF-7 Breast | 202 / 9217 (2.2%) | 6019 / 92170 (6.5%) | −77.2 | −75.2 | 0.34 |
| AR SRX1067066 | LHSAR Prostate | 452 / 9217 (4.9%) | 9708 / 92170 (10.5%) | −77.1 | −75.1 | 0.47 |
| RORC SRX5359052 | HCC70 Breast | 685 / 9217 (7.4%) | 2935 / 92170 (3.2%) | −77.1 | −75.1 | 2.33 |
| ESR1 SRX1012630 | MCF-7 Breast | 74 / 9217 (0.8%) | 3763 / 92170 (4.1%) | −77.0 | −75.0 | 0.20 |
| ESR1 SRX2513517 | MCF-7 Breast | 143 / 9217 (1.6%) | 5031 / 92170 (5.5%) | −77.0 | −75.0 | 0.28 |
| JUN SRX6582171 | GM07492 Others | 415 / 9217 (4.5%) | 9184 / 92170 (10.0%) | −77.0 | −75.0 | 0.45 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 456 / 9217 (4.9%) | 9755 / 92170 (10.6%) | −76.9 | −75.0 | 0.47 |
| MITF SRX1555436 | 501A Epidermis | 1022 / 9217 (11.1%) | 5278 / 92170 (5.7%) | −76.8 | −74.9 | 1.94 |
| SMARCA2 SRX8119677 | MeT-5A Others | 353 / 9217 (3.8%) | 8292 / 92170 (9.0%) | −76.7 | −74.7 | 0.43 |
| NR3C1 SRX19024870 | MCF-7 Breast | 63 / 9217 (0.7%) | 3531 / 92170 (3.8%) | −76.7 | −74.7 | 0.18 |
| AR SRX1067067 | LHSAR Prostate | 367 / 9217 (4.0%) | 8488 / 92170 (9.2%) | −76.6 | −74.7 | 0.43 |
| GRHL3 SRX2582162 | NHEK Epidermis | 572 / 9217 (6.2%) | 2222 / 92170 (2.4%) | −76.6 | −74.6 | 2.57 |
| ESR1 SRX8537722 | MCF-7 Breast | 197 / 9217 (2.1%) | 5915 / 92170 (6.4%) | −76.6 | −74.6 | 0.33 |
| ARID1A SRX5089382 | MCF-7 Breast | 151 / 9217 (1.6%) | 5149 / 92170 (5.6%) | −76.4 | −74.5 | 0.29 |
| JUNB SRX10119384 | MCF 10A Breast | 133 / 9217 (1.4%) | 4835 / 92170 (5.2%) | −76.3 | −74.3 | 0.28 |
| CXXC1 SRX1424886 | SEM Blood | 768 / 9217 (8.3%) | 3503 / 92170 (3.8%) | −76.3 | −74.3 | 2.19 |
| MethylCap SRX014767 | NB-4 Blood | 922 / 9217 (10.0%) | 4572 / 92170 (5.0%) | −76.2 | −74.3 | 2.02 |
| FOXA1 SRX1161203 | T-47D Breast | 158 / 9217 (1.7%) | 5259 / 92170 (5.7%) | −76.2 | −74.3 | 0.30 |
| Epitope tags SRX10549777 | K-562 Blood | 1285 / 9217 (13.9%) | 7268 / 92170 (7.9%) | −76.2 | −74.2 | 1.77 |
| CHD6 SRX17709200 | C4-2 Prostate | 841 / 9217 (9.1%) | 4008 / 92170 (4.3%) | −76.2 | −74.2 | 2.10 |
| FOS SRX3322636 | MCF-7 Breast | 139 / 9217 (1.5%) | 4930 / 92170 (5.3%) | −76.0 | −74.1 | 0.28 |
| YAP1 SRX5718140 | 293 Kidney | 374 / 9217 (4.1%) | 8556 / 92170 (9.3%) | −75.9 | −73.9 | 0.44 |
| ESR1 SRX5323877 | MCF-7 Breast | 167 / 9217 (1.8%) | 5398 / 92170 (5.9%) | −75.8 | −73.9 | 0.31 |
| FOXA1 SRX3923510 | MCF-7 Breast | 78 / 9217 (0.8%) | 3804 / 92170 (4.1%) | −75.8 | −73.9 | 0.21 |
| FOXA1 SRX3923508 | MCF-7 Breast | 62 / 9217 (0.7%) | 3483 / 92170 (3.8%) | −75.7 | −73.8 | 0.18 |
| JUND SRX190357 | SK-N-SH Neural | 280 / 9217 (3.0%) | 7162 / 92170 (7.8%) | −75.4 | −73.5 | 0.39 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 208 / 9217 (2.3%) | 6047 / 92170 (6.6%) | −75.3 | −73.3 | 0.34 |
| MECOM SRX23677890 | HNT-34 Blood | 956 / 9217 (10.4%) | 4841 / 92170 (5.3%) | −75.2 | −73.3 | 1.97 |
| NKX2-1 SRX2164786 | A549 Lung | 366 / 9217 (4.0%) | 8410 / 92170 (9.1%) | −75.0 | −73.1 | 0.44 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 103 / 9217 (1.1%) | 37 / 92170 (0.0%) | −75.0 | −73.0 | 27.84 |
| RUNX1 SRX2014504 | Jurkat Blood | 1267 / 9217 (13.7%) | 7170 / 92170 (7.8%) | −74.8 | −72.9 | 1.77 |
| FOXA1 SRX3931031 | MCF-7 Breast | 100 / 9217 (1.1%) | 4188 / 92170 (4.5%) | −74.6 | −72.6 | 0.24 |
| ESR1 SRX1469951 | MCF-7 Breast | 111 / 9217 (1.2%) | 4387 / 92170 (4.8%) | −74.6 | −72.6 | 0.25 |
| FOXA1 SRX5323844 | MCF-7 Breast | 55 / 9217 (0.6%) | 3302 / 92170 (3.6%) | −74.6 | −72.6 | 0.17 |
| EP300 SRX150579 | HeLa Uterus | 145 / 9217 (1.6%) | 4984 / 92170 (5.4%) | −74.5 | −72.6 | 0.29 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 286 / 9217 (3.1%) | 7220 / 92170 (7.8%) | −74.5 | −72.5 | 0.40 |
| ESR1 SRX792933 | LY2 Breast | 181 / 9217 (2.0%) | 5582 / 92170 (6.1%) | −74.5 | −72.5 | 0.32 |
| FOXA1 SRX1961157 | T-47D Breast | 245 / 9217 (2.7%) | 6594 / 92170 (7.2%) | −74.4 | −72.4 | 0.37 |
| ESR1 SRX176856 | MCF-7 Breast | 68 / 9217 (0.7%) | 3565 / 92170 (3.9%) | −74.3 | −72.4 | 0.19 |
| ESR1 SRX1531796 | MCF-7 Breast | 114 / 9217 (1.2%) | 4432 / 92170 (4.8%) | −74.2 | −72.3 | 0.26 |
| STAT3 SRX150479 | MCF 10A Breast | 210 / 9217 (2.3%) | 6039 / 92170 (6.6%) | −74.2 | −72.2 | 0.35 |
| ESR1 SRX1012628 | MCF-7 Breast | 108 / 9217 (1.2%) | 4320 / 92170 (4.7%) | −74.2 | −72.2 | 0.25 |
| ESR1 SRX20282959 | MCF-7 Breast | 87 / 9217 (0.9%) | 3929 / 92170 (4.3%) | −74.2 | −72.2 | 0.22 |
| JUND SRX150408 | HeLa Uterus | 196 / 9217 (2.1%) | 5807 / 92170 (6.3%) | −73.9 | −71.9 | 0.34 |
| ESR1 SRX5323871 | MCF-7 Breast | 239 / 9217 (2.6%) | 6480 / 92170 (7.0%) | −73.8 | −71.9 | 0.37 |
| MAU2 SRX11120893 | MCF-7 Breast | 85 / 9217 (0.9%) | 3876 / 92170 (4.2%) | −73.6 | −71.7 | 0.22 |
| VGLL1 SRX18013277 | FULVR Breast | 91 / 9217 (1.0%) | 3981 / 92170 (4.3%) | −73.4 | −71.4 | 0.23 |
| RORC SRX5359053 | HCC70 Breast | 657 / 9217 (7.1%) | 2827 / 92170 (3.1%) | −73.2 | −71.3 | 2.32 |
| RELA SRX2207673 | HUVEC Cardiovascular | 775 / 9217 (8.4%) | 13788 / 92170 (15.0%) | −73.2 | −71.3 | 0.56 |
| ESR1 SRX10365534 | MCF-7 Breast | 58 / 9217 (0.6%) | 3322 / 92170 (3.6%) | −73.0 | −71.1 | 0.17 |
| YAP1 SRX10119364 | MCF 10A Breast | 190 / 9217 (2.1%) | 5677 / 92170 (6.2%) | −73.0 | −71.1 | 0.33 |
| AHR SRX2378695 | MCF-7 Breast | 90 / 9217 (1.0%) | 3948 / 92170 (4.3%) | −72.8 | −70.9 | 0.23 |
| FOXA1 SRX6878603 | LNCAP Prostate | 244 / 9217 (2.6%) | 6520 / 92170 (7.1%) | −72.8 | −70.9 | 0.37 |
| NABP2 SRX9523535 | HT-1080 Bone | 716 / 9217 (7.8%) | 3227 / 92170 (3.5%) | −72.7 | −70.8 | 2.22 |
| CBX3 SRX6712570 | MCF-7 Breast | 175 / 9217 (1.9%) | 5425 / 92170 (5.9%) | −72.6 | −70.7 | 0.32 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 231 / 9217 (2.5%) | 6312 / 92170 (6.8%) | −72.6 | −70.7 | 0.37 |
| FOXA1 SRX1961158 | T-47D Breast | 228 / 9217 (2.5%) | 6268 / 92170 (6.8%) | −72.6 | −70.7 | 0.36 |
| JUN SRX2355072 | HAEC Cardiovascular | 292 / 9217 (3.2%) | 7237 / 92170 (7.9%) | −72.6 | −70.6 | 0.40 |
| FOXA1 SRX8537736 | MCF-7 Breast | 76 / 9217 (0.8%) | 3668 / 92170 (4.0%) | −72.5 | −70.6 | 0.21 |
| FOXA1 SRX5323850 | MCF-7 Breast | 51 / 9217 (0.6%) | 3149 / 92170 (3.4%) | −72.2 | −70.3 | 0.16 |
| FOXA1 SRX3923513 | MCF-7 Breast | 63 / 9217 (0.7%) | 3397 / 92170 (3.7%) | −72.2 | −70.3 | 0.19 |
| ESR1 SRX3110723 | MCF-7 Breast | 120 / 9217 (1.3%) | 4473 / 92170 (4.9%) | −72.2 | −70.3 | 0.27 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 979 / 9217 (10.6%) | 5093 / 92170 (5.5%) | −72.1 | −70.2 | 1.92 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 178 / 9217 (1.9%) | 5450 / 92170 (5.9%) | −72.0 | −70.1 | 0.33 |
| IRF3 SRX11453864 | Hep G2 Liver | 91 / 9217 (1.0%) | 23 / 92170 (0.0%) | −72.0 | −70.1 | 39.57 |
| HIF1A SRX8180621 | Peripheral blood mononuclear cells Blood | 114 / 9217 (1.2%) | 65 / 92170 (0.1%) | −71.9 | −70.0 | 17.54 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 738 / 9217 (8.0%) | 3398 / 92170 (3.7%) | −71.8 | −69.8 | 2.17 |
| MEN1 SRX11712604 | K-562 Blood | 735 / 9217 (8.0%) | 3378 / 92170 (3.7%) | −71.7 | −69.8 | 2.18 |
| NR3C1 SRX8520802 | HCC1187 Breast | 168 / 9217 (1.8%) | 5276 / 92170 (5.7%) | −71.7 | −69.8 | 0.32 |
| DAXX SRX1021630 | PC-3 Prostate | 225 / 9217 (2.4%) | 6187 / 92170 (6.7%) | −71.7 | −69.8 | 0.36 |
| STAT3 SRX150630 | MCF 10A Breast | 214 / 9217 (2.3%) | 6014 / 92170 (6.5%) | −71.6 | −69.7 | 0.36 |
| TET2 SRX1427029 | 293 Kidney | 674 / 9217 (7.3%) | 2973 / 92170 (3.2%) | −71.5 | −69.6 | 2.27 |
| TRPS1 SRX3401273 | MCF-7 Breast | 70 / 9217 (0.8%) | 3519 / 92170 (3.8%) | −71.5 | −69.6 | 0.20 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 700 / 9217 (7.6%) | 3148 / 92170 (3.4%) | −71.4 | −69.5 | 2.22 |
| ZEB1 SRX13298923 | MCF-7 Breast | 93 / 9217 (1.0%) | 3961 / 92170 (4.3%) | −71.4 | −69.5 | 0.23 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 67 / 9217 (0.7%) | 3457 / 92170 (3.8%) | −71.4 | −69.5 | 0.19 |
| ESR1 SRX1012625 | MCF-7 Breast | 116 / 9217 (1.3%) | 4374 / 92170 (4.7%) | −71.2 | −69.3 | 0.27 |
| FOXA1 SRX8537737 | MCF-7 Breast | 83 / 9217 (0.9%) | 3765 / 92170 (4.1%) | −71.2 | −69.3 | 0.22 |
| FOXA1 SRX1161207 | T-47D Breast | 93 / 9217 (1.0%) | 3947 / 92170 (4.3%) | −71.0 | −69.1 | 0.24 |
| ESR1 SRX5323876 | MCF-7 Breast | 119 / 9217 (1.3%) | 4415 / 92170 (4.8%) | −70.9 | −69.0 | 0.27 |
| CBFB SRX265218 | ME-1 Blood | 779 / 9217 (8.5%) | 3704 / 92170 (4.0%) | −70.7 | −68.8 | 2.10 |
| FOXA1 SRX3923509 | MCF-7 Breast | 63 / 9217 (0.7%) | 3354 / 92170 (3.6%) | −70.6 | −68.7 | 0.19 |
| FOXM1 SRX185907 | MCF-7 Breast | 39 / 9217 (0.4%) | 2838 / 92170 (3.1%) | −70.5 | −68.6 | 0.14 |
| FOXA1 SRX1161205 | T-47D Breast | 122 / 9217 (1.3%) | 4454 / 92170 (4.8%) | −70.5 | −68.6 | 0.27 |
| FOXA1 SRX3931073 | MCF-7 Breast | 136 / 9217 (1.5%) | 4698 / 92170 (5.1%) | −70.5 | −68.6 | 0.29 |
| AHR SRX20282969 | MCF-7 Breast | 102 / 9217 (1.1%) | 4096 / 92170 (4.4%) | −70.5 | −68.6 | 0.25 |
| MAU2 SRX11120892 | MCF-7 Breast | 92 / 9217 (1.0%) | 3913 / 92170 (4.2%) | −70.4 | −68.5 | 0.24 |
| ESR1 SRX8537723 | MCF-7 Breast | 180 / 9217 (2.0%) | 5428 / 92170 (5.9%) | −70.4 | −68.5 | 0.33 |
| CEBPB SRX190345 | MCF-7 Breast | 183 / 9217 (2.0%) | 5472 / 92170 (5.9%) | −70.2 | −68.3 | 0.33 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 61 / 9217 (0.7%) | 3300 / 92170 (3.6%) | −70.1 | −68.2 | 0.18 |
| ESR1 SRX1012631 | MCF-7 Breast | 98 / 9217 (1.1%) | 4009 / 92170 (4.3%) | −70.0 | −68.1 | 0.24 |
| KMT2A SRX2281249 | SEM Blood | 1000 / 9217 (10.8%) | 5306 / 92170 (5.8%) | −69.9 | −68.0 | 1.88 |
| RBFOX2 SRX4708082 | K-562 Blood | 1224 / 9217 (13.3%) | 6997 / 92170 (7.6%) | −69.8 | −67.9 | 1.75 |
| ESR1 SRX2513520 | MCF-7 Breast | 142 / 9217 (1.5%) | 4779 / 92170 (5.2%) | −69.8 | −67.9 | 0.30 |
| ESR1 SRX5323872 | MCF-7 Breast | 227 / 9217 (2.5%) | 6146 / 92170 (6.7%) | −69.7 | −67.8 | 0.37 |
| WWTR1 SRX10119367 | MCF 10A Breast | 273 / 9217 (3.0%) | 6846 / 92170 (7.4%) | −69.7 | −67.8 | 0.40 |
| FOXA1 SRX5323830 | T-47D Breast | 143 / 9217 (1.6%) | 4792 / 92170 (5.2%) | −69.6 | −67.8 | 0.30 |
| ESR1 SRX3080214 | MCF-7 Breast | 51 / 9217 (0.6%) | 3072 / 92170 (3.3%) | −69.5 | −67.6 | 0.17 |
| FOSL2 SRX190204 | A549 Lung | 232 / 9217 (2.5%) | 6216 / 92170 (6.7%) | −69.5 | −67.6 | 0.37 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1066 / 9217 (11.6%) | 5806 / 92170 (6.3%) | −69.5 | −67.6 | 1.84 |
| GFP SRX6949256 | HeLa Uterus | 246 / 9217 (2.7%) | 6430 / 92170 (7.0%) | −69.5 | −67.6 | 0.38 |
| EP300 SRX2671813 | Fibroblasts Others | 192 / 9217 (2.1%) | 5589 / 92170 (6.1%) | −69.5 | −67.6 | 0.34 |
| ERG SRX063921 | K-562 Blood | 773 / 9217 (8.4%) | 3693 / 92170 (4.0%) | −69.2 | −67.3 | 2.09 |
| NCOA3 SRX4663589 | MCF-7 Breast | 61 / 9217 (0.7%) | 3270 / 92170 (3.5%) | −69.2 | −67.3 | 0.19 |
| ESR1 SRX3123830 | MCF-7 Breast | 59 / 9217 (0.6%) | 3229 / 92170 (3.5%) | −69.1 | −67.3 | 0.18 |
| AR SRX9109110 | MDA-MB-453 Breast | 429 / 9217 (4.7%) | 9052 / 92170 (9.8%) | −69.1 | −67.3 | 0.47 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 247 / 9217 (2.7%) | 6429 / 92170 (7.0%) | −69.1 | −67.2 | 0.38 |
| ESR1 SRX5323878 | MCF-7 Breast | 229 / 9217 (2.5%) | 6154 / 92170 (6.7%) | −69.1 | −67.2 | 0.37 |
| JUNB SRX8488074 | SUM 229PE Breast | 312 / 9217 (3.4%) | 7392 / 92170 (8.0%) | −69.0 | −67.2 | 0.42 |
| FOXA1 SRX100477 | Hep G2 Liver | 268 / 9217 (2.9%) | 6742 / 92170 (7.3%) | −69.0 | −67.1 | 0.40 |
| LARP7 SRX2198835 | HeLa Uterus | 1096 / 9217 (11.9%) | 6046 / 92170 (6.6%) | −69.0 | −67.1 | 1.81 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 188 / 9217 (2.0%) | 5506 / 92170 (6.0%) | −69.0 | −67.1 | 0.34 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 150 / 9217 (1.6%) | 4881 / 92170 (5.3%) | −68.9 | −67.0 | 0.31 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 401 / 9217 (4.4%) | 8651 / 92170 (9.4%) | −68.8 | −66.9 | 0.46 |
| PROX1 SRX3230397 | Hep G2 Liver | 172 / 9217 (1.9%) | 5237 / 92170 (5.7%) | −68.6 | −66.7 | 0.33 |
| ING2 SRX286201 | RKO Digestive tract | 726 / 9217 (7.9%) | 3386 / 92170 (3.7%) | −68.6 | −66.7 | 2.14 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 308 / 9217 (3.3%) | 7319 / 92170 (7.9%) | −68.6 | −66.7 | 0.42 |
| CDK9 SRX20230574 | Ishikawa Uterus | 787 / 9217 (8.5%) | 3809 / 92170 (4.1%) | −68.5 | −66.6 | 2.07 |
| RELA SRX5938177 | FaDu Others | 213 / 9217 (2.3%) | 5884 / 92170 (6.4%) | −68.5 | −66.6 | 0.36 |
| KDM6A SRX15826236 | MCF-7 Breast | 73 / 9217 (0.8%) | 3490 / 92170 (3.8%) | −68.4 | −66.5 | 0.21 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 96 / 9217 (1.0%) | 3922 / 92170 (4.3%) | −68.4 | −66.5 | 0.24 |
| MECOM SRX23677891 | HNT-34 Blood | 926 / 9217 (10.0%) | 4805 / 92170 (5.2%) | −68.3 | −66.5 | 1.93 |
| ZFX SRX7805370 | 293 Kidney | 594 / 9217 (6.4%) | 2512 / 92170 (2.7%) | −68.3 | −66.5 | 2.36 |
| ARID1A SRX5089380 | MCF-7 Breast | 84 / 9217 (0.9%) | 3696 / 92170 (4.0%) | −68.3 | −66.4 | 0.23 |
| GATAD2A SRX2636506 | Hep G2 Liver | 304 / 9217 (3.3%) | 7243 / 92170 (7.9%) | −68.2 | −66.4 | 0.42 |
| FOXA1 SRX5203314 | MCF-7 Breast | 31 / 9217 (0.3%) | 2586 / 92170 (2.8%) | −68.2 | −66.4 | 0.12 |
| FOXA1 SRX497612 | VCaP Prostate | 224 / 9217 (2.4%) | 6037 / 92170 (6.5%) | −68.0 | −66.2 | 0.37 |
| ESR1 SRX11120903 | MCF-7 Breast | 204 / 9217 (2.2%) | 5725 / 92170 (6.2%) | −68.0 | −66.1 | 0.36 |
| TLE3 SRX4815194 | SUM 149PT Breast | 182 / 9217 (2.0%) | 5372 / 92170 (5.8%) | −67.9 | −66.1 | 0.34 |
| ESR1 SRX2513519 | MCF-7 Breast | 125 / 9217 (1.4%) | 4426 / 92170 (4.8%) | −67.9 | −66.1 | 0.28 |
| ESR1 SRX20282966 | MCF-7 Breast | 78 / 9217 (0.8%) | 3568 / 92170 (3.9%) | −67.9 | −66.1 | 0.22 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 223 / 9217 (2.4%) | 6011 / 92170 (6.5%) | −67.7 | −65.9 | 0.37 |
| ESR1 SRX4451214 | MCF-7 Breast | 204 / 9217 (2.2%) | 5715 / 92170 (6.2%) | −67.7 | −65.9 | 0.36 |
| ESR1 SRX2513518 | MCF-7 Breast | 113 / 9217 (1.2%) | 4204 / 92170 (4.6%) | −67.6 | −65.8 | 0.27 |
| PBX3 SRX190343 | SK-N-SH Neural | 475 / 9217 (5.2%) | 9615 / 92170 (10.4%) | −67.6 | −65.8 | 0.49 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 197 / 9217 (2.1%) | 5603 / 92170 (6.1%) | −67.6 | −65.7 | 0.35 |
| RELA SRX2207672 | HUVEC Cardiovascular | 850 / 9217 (9.2%) | 14446 / 92170 (15.7%) | −67.5 | −65.7 | 0.59 |
| FOXA1 SRX3923512 | MCF-7 Breast | 63 / 9217 (0.7%) | 3263 / 92170 (3.5%) | −67.5 | −65.7 | 0.19 |
| STAT1 SRX23678708 | K-562 Blood | 783 / 9217 (8.5%) | 3806 / 92170 (4.1%) | −67.5 | −65.7 | 2.06 |
| FOXA1 SRX190282 | A549 Lung | 167 / 9217 (1.8%) | 5113 / 92170 (5.5%) | −67.4 | −65.6 | 0.33 |
| FOXA1 SRX6860635 | T-47D Breast | 179 / 9217 (1.9%) | 5307 / 92170 (5.8%) | −67.4 | −65.6 | 0.34 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 180 / 9217 (2.0%) | 5326 / 92170 (5.8%) | −67.4 | −65.6 | 0.34 |
| NR3C1 SRX19024880 | MCF-7 Breast | 58 / 9217 (0.6%) | 3158 / 92170 (3.4%) | −67.4 | −65.6 | 0.18 |
| FOXA1 SRX3322087 | MCF-7 Breast | 39 / 9217 (0.4%) | 2744 / 92170 (3.0%) | −67.1 | −65.3 | 0.14 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 270 / 9217 (2.9%) | 6697 / 92170 (7.3%) | −67.0 | −65.2 | 0.40 |
| FOXA1 SRX5203311 | MCF-7 Breast | 35 / 9217 (0.4%) | 2647 / 92170 (2.9%) | −67.0 | −65.2 | 0.13 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 403 / 9217 (4.4%) | 8605 / 92170 (9.3%) | −67.0 | −65.2 | 0.47 |
| FOXA1 SRX6878604 | LNCAP Prostate | 191 / 9217 (2.1%) | 5485 / 92170 (6.0%) | −66.9 | −65.1 | 0.35 |
| KMT2C SRX1787675 | MCF-7 Breast | 206 / 9217 (2.2%) | 5718 / 92170 (6.2%) | −66.9 | −65.1 | 0.36 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 230 / 9217 (2.5%) | 6090 / 92170 (6.6%) | −66.9 | −65.0 | 0.38 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 281 / 9217 (3.0%) | 6853 / 92170 (7.4%) | −66.9 | −65.0 | 0.41 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 157 / 9217 (1.7%) | 4929 / 92170 (5.3%) | −66.8 | −65.0 | 0.32 |
| ESR1 SRX5534831 | MCF-7 Breast | 182 / 9217 (2.0%) | 5334 / 92170 (5.8%) | −66.7 | −64.9 | 0.34 |
| FOXA1 SRX3923525 | ZR-75-1 Breast | 81 / 9217 (0.9%) | 3594 / 92170 (3.9%) | −66.7 | −64.9 | 0.23 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 924 / 9217 (10.0%) | 4836 / 92170 (5.2%) | −66.7 | −64.9 | 1.91 |
| EP300 SRX190256 | MCF-7 Breast | 39 / 9217 (0.4%) | 2728 / 92170 (3.0%) | −66.7 | −64.8 | 0.14 |
| FOXA1 SRX219284 | LNCAP Prostate | 314 / 9217 (3.4%) | 7328 / 92170 (8.0%) | −66.6 | −64.8 | 0.43 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 271 / 9217 (2.9%) | 6696 / 92170 (7.3%) | −66.5 | −64.7 | 0.40 |
| FOXA1 SRX15431000 | T-47D Breast | 199 / 9217 (2.2%) | 5592 / 92170 (6.1%) | −66.5 | −64.7 | 0.36 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 247 / 9217 (2.7%) | 6329 / 92170 (6.9%) | −66.4 | −64.6 | 0.39 |
Showing first 500 of 15193 rows.